Mitral Valve Repair Surgery in a Patient With Sickle Cell Disease

Anthony Lemaire, Peter Scholz, Antonio Chiricolo, Andrew Israel, Leonard Y. Lee

Abstract


Sickle cell disease (SCD) affects between 70,000 and 100,000 Americans, making it one of the most prevalent genetic disorders in the United States. It is an autosomal, recessive disorder characterized by a single amino acid change in the betaglobin chain of hemoglobin (Hob) leading to its pathological polymerization, red cell rigidity and poor microvascular blood flow. These changes also produce the characteristic sickle shape of the red cells, which lose the pliability required to successfully traverse small capillaries. The use of cardiopulmonary bypass (CPB) during adult cardiac surgery initiates many of the conditions that contribute to the sickling of the hemoglobin S cells. Traditionally during CPB the patients are hypothermic and can become acidotic during intermediate periods of surgery. The experience of adult cardiac surgery with CPB on patients with SCD is limited. The purpose of our manuscript is to review the first case of adult cardiac surgery in a patient with SCD at our institution and also to review the literature on the management of patients with SCD who undergo adult cardiac surgery.




J Hematol. 2014;3(1):10-12
doi: http://dx.doi.org/10.14740/jh102w

Keywords


Sickle cell disease; Mitral valve; Crisis

Full Text: HTML PDF
 
Home     |     Log In     |      About     |      Search     |      Current     |      Archives     |      Submit      |     Subscribe


 

     

Aims and Scope

Current Issues

Conflict of Interest

About Publisher

Editorial Board

Archives

Copyright

Company Profile

Editorial Office

Misconduct and Retraction

Permissions

Company Registration

Contact Us

Abstracting and Indexing

ICMJE

Ownership

Instructions to Authors

Access

Declaration of Helsinki

Contact Publisher

Submission Checklist

Reprints

Terms of Use

Company Address

Submit a Manuscript

Open Access Policy

Privacy Policy

Browse Journals

Publishing Fee

Publishing Policy

Disclaimer

Recent Highlights

Peer-Review Process

Publishing Quality

Code of Ethics

Advertising Policy

Manuscript Tracking

Advanced Search

For Librarians

Careers

Publishing Process

Publication Frequency

For Reviewers

Propose a New Journal

       
       

Journal of Hematology, quarterly, ISSN 1927-1212 (print), 1927-1220 (online), published by Elmer Press Inc.            
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC BY-NC 4.0)



This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.thejh.org    editorial contact: editor@thejh.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
 

© Elmer Press Inc. All Rights Reserved.

IMPORTANT: THIS JOURNAL SITE OUTLOOK IS DESIGNED BY THE PUBLISHER AND COPYRIGHT PROTECTED. DO NOT COPY!